...
首页> 外文期刊>Khyber Medical University Journal >Comparative Study of Branched Chain Amino Acids Infusion with Conventional treatment in patients with Hepatic Encephalopathy due to Liver Cirrhosis
【24h】

Comparative Study of Branched Chain Amino Acids Infusion with Conventional treatment in patients with Hepatic Encephalopathy due to Liver Cirrhosis

机译:肝硬化合并肝性脑病患者常规输注支链氨基酸的比较研究

获取原文
           

摘要

OBJECTIVE: To determine the effectiveness of branched chain aminoacid (BCAA) infusion with conventional therapy in the treatment ofhepatic encephalopathy (HE) due to liver cirrhosis.METHODOLOGY: This was a hospital based randomized controlledtrial, conducted in the department of medicine, Lady Reading Hospital,Peshawar from February 2012 to July 2012.A total number of 86 patients, of either gender, presenting with gradeII, III and IV HE due to cirrhosis were included in the study. They wererandomly allocated into two groups by lottery method. Forty threepatients in group A were subjected to conventional treatment plus infusion?of BCAA (Aminoleban, Otsuka); while 43 patients in group B weresubjected to conventional treatment only, which consisted of antibioticsand lactulose. Data analysis was performed using SPSS version 20. ‘Chisquare' test was used to compare the effectiveness in both groups withp value of 0.05 as significant.RESULTS: Out of 86 patients included in the study, 52(60.5%) weremales and 34 (39.5%) were females. Mean age of the sample was49.73±7.958 years with age range from 35 to 70 years. After the administration?of BCAA infusion twice daily for 3 days, clinical improvement?was observed in 33 (76.7%) patients in group A while in group B only?10 (23.3%) patients improved clinically, showing p-value 0.001.CONCLUSION: Branched chain amino acids infusion is more effectivethan conventional therapy in the treatment of HE due to liver cirrhosis.KEY WORDS: Hepatic Encephalopathy, Chronic Liver Disease, Branched Chain Amino acids.
机译:目的:确定支链氨基酸(BCAA)常规疗法输注治疗肝硬化引起的肝性脑病(HE)的有效性。方法:这是一家基于医院的随机对照试验,在Lady Reading医院医学部进行(2012年2月至2012年7月,白沙瓦)。该研究共纳入86位男女患者,由于肝硬化而出现II,III和IV级HE。他们通过抽奖方法随机分为两组。 A组的43名患者接受常规治疗加BCAA(Aminoleban,大冢)输液。 B组43例仅接受常规治疗,包括抗生素和乳果糖。使用SPSS 20版进行数据分析。使用“ Chisquare”检验比较两组的有效性,p值<0.05为显着。结果:在研究的86名患者中,有52名(60.5%)为男性,其中34名为男性。 39.5%)是女性。样本的平均年龄为49.73±7.958岁,年龄范围为35至70岁。每天两次连续3天给予BCAA输注后,A组的33名患者(76.7%)观察到临床改善,而B组中仅有10名(23.3%)的患者临床改善,显示p值<0.001。结论:支链氨基酸输注治疗肝硬化引起的HE比常规治疗更有效。关键词:肝性脑病,慢性肝病,支链氨基酸

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号